HSBC Reiterates “€41.00” Price Target for Siemens Healthineers (ETR:SHL)

Share on StockTwits

HSBC set a €41.00 ($47.67) target price on Siemens Healthineers (ETR:SHL) in a research report sent to investors on Friday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

A number of other equities analysts have also recently issued reports on the company. Independent Research set a €38.50 ($44.77) target price on Siemens Healthineers and gave the stock a neutral rating in a report on Monday, May 6th. Morgan Stanley raised their price objective on Visa from $175.00 to $191.00 and gave the company an overweight rating in a report on Thursday. JPMorgan Chase & Co. set a €33.40 ($38.84) price objective on Siemens Healthineers and gave the company a neutral rating in a report on Thursday. Nord/LB set a €90.00 ($104.65) price objective on Henkel AG & Co KGaA and gave the company a neutral rating in a report on Tuesday, May 7th. Finally, Goldman Sachs Group upgraded Altria Group from a neutral rating to a buy rating and set a $59.00 price objective for the company in a report on Thursday. Fourteen investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The stock currently has an average rating of Hold and a consensus target price of €38.26 ($44.49).

SHL stock opened at €35.42 ($41.18) on Friday. The business’s 50-day moving average price is €36.70. The company has a market cap of $35.42 billion and a PE ratio of 25.85. The company has a debt-to-equity ratio of 51.25, a quick ratio of 0.83 and a current ratio of 1.31. Siemens Healthineers has a 1 year low of €31.90 ($37.09) and a 1 year high of €39.95 ($46.45).

Siemens Healthineers Company Profile

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Read More: Trading on Margin

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

JPMorgan Chase & Co. Increases AvalonBay Communities  Price Target to $224.00
JPMorgan Chase & Co. Increases AvalonBay Communities Price Target to $224.00
Brightsphere Investment Group  Lifted to “Hold” at Zacks Investment Research
Brightsphere Investment Group Lifted to “Hold” at Zacks Investment Research
PLDT  Rating Lowered to Hold at Zacks Investment Research
PLDT Rating Lowered to Hold at Zacks Investment Research
AtriCure  Stock Rating Lowered by Northland Securities
AtriCure Stock Rating Lowered by Northland Securities
Bradesco Corretora Reiterates “Neutral” Rating for Ternium
Bradesco Corretora Reiterates “Neutral” Rating for Ternium
Meridian Bioscience  Rating Lowered to Sell at ValuEngine
Meridian Bioscience Rating Lowered to Sell at ValuEngine


 
© 2006-2019 Zolmax.